During a soccer tournament with participation of 6,600 boys and girls (9-19 years) all injuries were evaluated, 5.2% of the players were injured; out of these 51% had "slight injuries", 42% "moderate injuries" and 7% "severe injuries". For the individual player the incidence of injury was 19.1/1,000 playing hours including all degrees of injuries; if "slight injuries" were excluded the incidence was 9.4/1,000 playing hours. The incidence rose with increasing age, girls were injured more often than boys. There were 81% of all injuries localised to the lower extremity, especially the ankle and foot. Contusion was the most frequent diagnosis, amounting to a third of all injuries. Blisters and exoriations amounted to nearly a fifth, 4% of the injuries were fractures, especially in the upper extremity; overuse injuries were seen only in 5.2% of the cases. Based on examination of the injury pattern in these children, injuries of youth seem to be relatively rare and mostly of a non-severe character.
Background: Cerebral venous thrombosis is a rare cause of stroke in adults especially in the young. It is a diagnostic and therapeutic challenge for the physician, given the wide spectrum of its clinical presentation. The purpose of the present study is to describe the clinical features, risk factors, radiological findings and outcome in a patient of Cerebral venous thrombosis. Objective: To study clinical profile, radiological findings and risk factors in patients with cerebral venous thrombosis amongst study participants. Material and Method: The prospective observational study was conducted on 60 patients admitted in department of General Medicine at tertiary health care institute at Nashik. Written informed consent was taken from all the study participants, and those who gave consent and satisfy eligibility criteria were enrolled in the present study between August 2017 to December 2019 with a radiologically confirmed diagnosis of cerebral venous thrombosis. Detailed history, clinical examination, laboratory investigations were carried out in all the cases and followed until discharge from the hospital or death. All the data will be analysed by applying appropriate statistical tests Microsoft Excel 2010. Results: Majority of incidence was seen in 18-30 age group comprising 50% of the cases, with equal sex distribution. Mean age of patient was found to be 37.3 years. Most patient had subacute onset with headache (76.67%) being the commonest presenting symptoms followed by convulsions and focal deficit in 46.67%. Hemiparesis 43.67% followed by papilloedema 33% were the most common neurological signs. Hyperhomocystinemia 33.67% and Protein S deficiency 20% were the most common risk factors identified in males whereas anemia 60% and puerperium 26.67% were most common in females. Transverse sinus (66.33%) was most common sinus involved radiologically followed by superior sagittal sinus in 43.67%. In 90% of the cases Low Molecular Weight Heparin [LMWH] was given and remaining 10% were given intravenous unfractionated heparin. 14% cases underwent decompressive surgery. Mortality was found to be 6.33% in the present study. Conclusion: High index of suspicion required for diagnosis of Cerebral venous thrombosis. The clinical presentation is nonspecific, can vary significantly and often makes the diagnosis of quite puzzling. MRI brain and MR Venogram are necessary for establishing a diagnosis. Patients are treated with anticoagulants, antiepileptics and antiedema measures and surgical decompression in case of continuing deterioration, in spite of maximum medical management. Cerebral venous thrombosis has a good prognosis unlike arterial ischemic stroke if the acute stage of illness has been survived.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.